Retatrutide – 20mg

Retatrutide is a next-generation synthetic peptide designed to activate multiple metabolic pathways,
including GLP-1, GIP, and glucagon receptors. This unique triple-agonist action has made it a strong
candidate in research for obesity management, glycemic control, and energy expenditure studies.
Its ability to target multiple receptors simultaneously has positioned Retatrutide as a promising
compound for advanced metabolic research.

Potential Research Benefits

• Explored for weight management research
• Studied for glucose metabolism & insulin sensitivity
• Supports energy expenditure studies
• Potential in multi-receptor metabolic research

Scientific Background

Retatrutide’s mechanism of action is centered around its ability to simultaneously stimulate
GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide),
and glucagon receptors. By engaging these key pathways, it may influence appetite regulation,
glucose homeostasis, and lipid metabolism. Preclinical studies suggest significant
improvements in body weight reduction and glycemic control, making it one of the most
advanced peptides currently being investigated in metabolic research.

Product Details

• Compound: Retatrutide
• Form: Lyophilized Powder
• Amount: 20mg per vial
• Purity: ≥99%
• Appearance: White to off-white powder
• Research Use Only: Not for human consumption